{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:45:19Z","timestamp":1791161119316,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T00:00:00Z","timestamp":1430524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12889-015-1779-1","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T04:37:01Z","timestamp":1430455021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France"],"prefix":"10.1186","volume":"15","author":[{"given":"Didier","family":"Riethmuller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Carole","family":"Jacquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lacau St Guily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Carcopino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Dahlab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Pr\u00e9tet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,2]]},"reference":[{"key":"1779_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1758-3284-2-15","volume":"2","author":"F Dayyani","year":"2010","unstructured":"Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010;2:15.","journal-title":"Head Neck Oncol"},{"issue":"7","key":"1779_CR2","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/ijc.24116","volume":"124","author":"H De Vuyst","year":"2009","unstructured":"De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124(7):1626\u201336.","journal-title":"Int J Cancer"},{"key":"1779_CR3","doi-asserted-by":"publisher","first-page":"c1439","DOI":"10.1136\/bmj.c1439","volume":"340","author":"H Mehanna","year":"2010","unstructured":"Mehanna H, Jones TM, Gregoire V, Ang KK. Oropharyngeal carcinoma related to human papillomavirus. BMJ. 2010;340:c1439.","journal-title":"BMJ"},{"issue":"10","key":"1779_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jcp.2008.063149","volume":"62","author":"C Miralles-Guri","year":"2009","unstructured":"Miralles-Guri C, Bruni L, Cubilla AL, Castellsague X, Bosch FX, de Sanjose S. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009;62(10):870\u20138.","journal-title":"J Clin Pathol"},{"issue":"Suppl 2","key":"1779_CR5","first-page":"S47","volume":"17","author":"N Bhatia","year":"2013","unstructured":"Bhatia N, Lynde C, Vender R, Bourcier M. Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus. J Cutan Med Surg. 2013;17 Suppl 2:S47\u201354.","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"1779_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","author":"LL Villa","year":"2005","unstructured":"Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6(5):271\u20138.","journal-title":"Lancet Oncol"},{"issue":"10","key":"1779_CR7","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","volume":"37","author":"DR Brown","year":"1999","unstructured":"Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol. 1999;37(10):3316\u201322.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1779_CR8","first-page":"91","volume":"16","author":"M Potocnik","year":"2007","unstructured":"Potocnik M, Kocjan BJ, Seme K, Poljak M. Distribution of human papillomavirus (HPV) genotypes in genital warts from males in Slovenia. Acta Dermatovenerol Alp Panonica Adriat. 2007;16(3):91\u20136. 98.","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"1779_CR9","unstructured":"2013 vaccination schedule and recommendations from the \u201cHaut Conseil de la sant\u00e9 publique\u201d in France. BEH. 2013;14-15:129-158."},{"issue":"11","key":"1779_CR10","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1779_CR11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ijc.25396","volume":"128","author":"N Li","year":"2011","unstructured":"Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128(4):927\u201335.","journal-title":"Int J Cancer"},{"key":"1779_CR12","doi-asserted-by":"crossref","unstructured":"HPV vaccine works against nine viral types. Cancer Discov. 2014;4(1):OF2.","DOI":"10.1158\/2159-8290.CD-NB2013-168"},{"issue":"1","key":"1779_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-9378-7-38","volume":"7","author":"B Serrano","year":"2012","unstructured":"Serrano B, Alemany L, Tous S, Bruni L, Clifford GM, Weiss T, et al. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer. 2012;7(1):38.","journal-title":"Infect Agent Cancer"},{"issue":"2","key":"1779_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ijc.23092","volume":"122","author":"JL Pretet","year":"2008","unstructured":"Pretet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B, et al. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer. 2008;122(2):428\u201332.","journal-title":"Int J Cancer"},{"issue":"2","key":"1779_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ijc.23093","volume":"122","author":"JL Pretet","year":"2008","unstructured":"Pretet JL, Jacquard AC, Carcopino X, Monnier-Benoit S, Averous G, Soubeyrand B, et al. Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2\/3) in France: EDITH study. Int J Cancer. 2008;122(2):424\u20137.","journal-title":"Int J Cancer"},{"issue":"2","key":"1779_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ygyno.2008.04.012","volume":"110","author":"JL Pretet","year":"2008","unstructured":"Pretet JL, Jacquard AC, Saunier M, Clavel C, Dachez R, Gondry J, et al. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2\/3 and invasive cervical cancer: the EDiTH III study. Gynecol Oncol. 2008;110(2):179\u201384.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1779_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1086\/590560","volume":"47","author":"F Aubin","year":"2008","unstructured":"Aubin F, Pretet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, et al. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis. 2008;47(5):610\u20135.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1779_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ijc.25671","volume":"129","author":"L Abramowitz","year":"2011","unstructured":"Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, et al. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer. 2011;129(2):433\u20139.","journal-title":"Int J Cancer"},{"issue":"2","key":"1779_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jcv.2011.03.003","volume":"51","author":"J Lacau St Guily","year":"2011","unstructured":"Lacau St Guily J, Jacquard AC, Pretet JL, Haesebaert J, Beby-Defaux A, Clavel C, et al. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France\u2013The EDiTH VI study. J Clin Virol. 2011;51(2):100\u20134.","journal-title":"J Clin Virol"},{"key":"1779_CR20","unstructured":"Haut conseil de la sant\u00e9 publique. Avis sur la modification \u00e9ventuelle des recommandations vaccinales des jeunes femmes par le vaccin anti-papillomavirus Gardasil\u00ae. HCSP. Paris, 2008. www.hcsp.fr\/hcspi\/docspdf\/avisrapports\/hcspa20080201_Gardasil.pdf (Visited on 04\/12\/2014)."},{"key":"1779_CR21","first-page":"22","volume":"362","author":"P Judlin","year":"2011","unstructured":"Judlin P, Riethmuller D. Epid\u00e9miologie de l\u2019infection due \u00e0 HPV chez la femme apr\u00e8s conisation. Lettre du gyn\u00e9cologue. 2011;362:22\u20134.","journal-title":"Lettre du gyn\u00e9cologue"},{"issue":"5","key":"1779_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jgyn.2009.04.008","volume":"38","author":"D Riethmuller","year":"2009","unstructured":"Riethmuller D, Pretet JL, Denis F, Aubin F, Pradat P, Clavel C, et al. Expected impact of a quadrivalent HPV vaccine in France. J Gynecol Obstet Biol Reprod. 2009;38(5):389\u201395.","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"1779_CR23","unstructured":"Vaccination against Human Papillomavirus infections. Annual report 2014. Haut Conseil de la Sant\u00e9 Publique. http:\/\/www.hcsp.fr\/Explore.cgi\/Telecharger?NomFichier=hcspr20140710_vachpvdonneesactualisees.pdf (Visited March 27, 2015)."},{"issue":"7","key":"1779_CR24","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/1055-9965.EPI-07-2922","volume":"17","author":"RP Insinga","year":"2008","unstructured":"Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1611\u201322.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"1779_CR25","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/ijc.24528","volume":"125","author":"N Wentzensen","year":"2009","unstructured":"Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009;125(9):2151\u20138.","journal-title":"Int J Cancer"},{"issue":"22","key":"1779_CR26","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/jnci\/djs395","volume":"104","author":"N Van de Velde","year":"2012","unstructured":"Van de Velde N, Boily MC, Drolet M, Franco EL, Mayrand MH, Kliewer EV, et al. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis. J Natl Cancer Inst. 2012;104(22):1712\u201323.","journal-title":"J Natl Cancer Inst"},{"key":"1779_CR27","unstructured":"Les vaccins anti-papillomavirus humains (HPV). French Ministry of Health. http:\/\/www.sante.gouv.fr\/questions-reponses-vaccin-anti-papillomavirus-humain-gardasil-r.html (Visited April 2, 2015)."},{"key":"1779_CR28","unstructured":"European Medicines Agency. Gardasil - Summary of Product Characteristics (Updated November 2013). http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000703\/WC500021142.pdf (Visited March 31, 2015)."},{"issue":"9","key":"1779_CR29","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/ijc.28541","volume":"134","author":"M Drolet","year":"2014","unstructured":"Drolet M, Laprise JF, Boily MC, Franco EL, Brisson M. Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine. Int J Cancer. 2014;134(9):2264\u20138.","journal-title":"Int J Cancer"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-015-1779-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-1779-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-1779-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-1779-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:59:41Z","timestamp":1630569581000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-015-1779-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1779"],"URL":"https:\/\/doi.org\/10.1186\/s12889-015-1779-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725583719.793532231","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,2]]},"assertion":[{"value":"27 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"453"}}